Help Discover Better Treatments

Our team of experts works to understand why eye diseases progress differently from person to person and uses what we learn to develop better medicines.

We invite you to join our community of patients dedicated to finding effective treatments for progressive diseases.

Through our proprietary disease intelligence system, Character Arc, we partner with patients and physicians to study how medical history, genetics, and lifestyle factors contribute to disease progression.  

Our goal is to discover and develop targeted therapies to more effectively treat patients.

Your Participation Matters

Contribute to our knowledge of eye diseases to help discover more effective, targeted treatments for you and others

Receive information that could assist you in your routine care and health monitoring

Potentially be invited to participate in a clinical trial to test a new treatment

Observational Research Initiatives

ACTIVE
Age-Related Macular Degeneration (AMD) Progression Study
This longitudinal, observational study aims to discover the  drivers and predictors of AMD progression to develop targeted therapies for earlier and effective intervention.
ACTIVE
Primary Open-Angle Glaucoma (POAG) Progression Study
This longitudinal, observational study aims to discover the drivers and predictors of POAG progression to develop targeted therapies for effective intervention.
Completed
Diversity Study
This study enrolled people of diverse backgrounds to understand genetic and lifestyle risks and protective factors related to the development of ophthalmic diseases.

Interested in learning more about our studies?